Development of immune monitoring reagents and MHC typing technologies
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN266200400101C
- Awardee
-
Beth Israel Deaconess Medical Center, Inc. UEI C1CPANL3EWK4 Part of New England Deaconess Hospital
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,867,622
Award facts
- Opportunity
-
- NIHNIAIDDAIT0424 Solicitation number
- Contract value 42% obligated
-
- $8,146,002.00 Current, with exercised options
- $14,104,415.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- C118 Research And Development Facilities
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers
- Pricing
- Cost No Fee
- Place of performance
- Boston, MA 02215, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,215,116 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $1,185,636 | |
| Other Administrative Action | $1,156,909 | |
| Funding Only Action | $1,155,906 | |
| Original award | $1,154,055 |
About this award
The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $14,104,415.00 cost-no-fee contract to Beth Israel Deaconess Medical Center, Inc. (BIDMC) for the "DEVELOPMENT OF IMMUNE MONITORING REAGENTS AND MHC TYPING TECHNOLOGIES". This definitive contract, awarded on September 30, 2004, has an ultimate completion date of September 29, 2009. BIDMC, a non-profit academic medical center and teaching hospital affiliated with Harvard Medical School, is the prime contractor. The contract is not set aside and was competed in the open market. BIDMC has an extensive portfolio of federal grants and contracts, reflecting its broad research capabilities in areas such as cardiovascular health, cancer, neuroscience, and infectious diseases.
Quick answers
Who was awarded contract HHSN266200400101C?
HHSN266200400101C was awarded to Beth Israel Deaconess Medical Center, Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on September 30, 2004.
How much is contract HHSN266200400101C worth?
The government has obligated $5,867,622 on HHSN266200400101C. Its current value, with exercised options, is $8,146,002. Its potential value, with all options, is $14,104,415.
Was contract HHSN266200400101C competed?
The extent of competition for HHSN266200400101C was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award